← European Medicine Shortage Tracker · all medicines

Paliperidone palmitate shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Paliperidone palmitate currently has availability issues reported in 2 European registers: EU-wide, Ireland.

Shortage  ATC — · also listed as: Paliperidone palmitate · data refreshed 9 September 2026

Key facts

As of 9 September 2026, 2 of the 9 tracked registers list current availability issues for Paliperidone palmitate, covering 5 affected product presentations. The longest-running open report was filed in Ireland on 2025-12-09 and has now been open for about 9 months. Where agencies state a cause, quality issues lead with 4 of the 4 stated-cause reports. The furthest expected-resolution date currently on file is 2027-03-30; the earliest is 2027-03-30. Registers in EU-wide, Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

Shortage Listed in the EMA shortages catalogue — EU-level issue. EMA lists available alternatives — see the EMA record. EMA record ↗
WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇺 EU-wide (EMA)Shortage
Paliperidone palmitate
2026-08-27Schizophrenia
Alternatives: EMA lists available alternatives — see the EMA record.
register ↗
🇮🇪 IrelandShortage
Palmeux 100 mg prolonged-release suspension for injection in pre-filled
+ 3 more products
Palmeux 150 mg prolonged-release suspension for injection in pre-filled
Palmeux 50 mg prolonged-release suspension for injection in pre-filled s
Palmeux 75 mg prolonged-release suspension for injection in pre-filled s
2025-12-092027-03-30Quality issue
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2025-12: 42026-01: 02026-02: 02026-03: 02026-04: 02026-05: 02026-06: 02026-07: 02026-08: 12025-122026-08

Full report history (5 register entries)

Every individual register entry for Paliperidone palmitate in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇪🇺 EUPaliperidone palmitateShortage2026-08-27Schizophrenia
🇮🇪 IEPalmeux 100 mg prolonged-release suspension for injection in pre-filleShortage2025-12-092027-03-30Quality issue
🇮🇪 IEPalmeux 150 mg prolonged-release suspension for injection in pre-filleShortage2025-12-092027-03-30Quality issue (Multiple countries)
🇮🇪 IEPalmeux 50 mg prolonged-release suspension for injection in pre-filledShortage2025-12-092027-03-30Quality issue (Multiple countries)
🇮🇪 IEPalmeux 75 mg prolonged-release suspension for injection in pre-filledShortage2025-12-092027-03-30Quality issue (Multiple countries)

Frequently asked

Is Paliperidone palmitate currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: EU-wide (EMA), Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Paliperidone palmitate shortage expected to end?

Agency prognoses on file range from 2027-03-30 to 2027-03-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Paliperidone palmitate?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Paliperidone palmitate availability data come from?

Directly from the official medicines-agency registers that list Paliperidone palmitate: EMA shortages catalogue (EU), HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Paliperidone palmitate — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paliperidone-palmitate/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Paliperidone palmitate availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/paliperidone-palmitate/">Paliperidone palmitate shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Paliperidone palmitate: availability status across 2 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.